NCT07753954 Medical Imaging to Re-evaluate Elacestrant Clinical Usage Status NOT_YET_RECRUITING Phase PHASE2
NCT07222215 PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) Status RECRUITING Phase PHASE2
NCT06828848 A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections Status RECRUITING Phase PHASE2
NCT05512364 Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) Status RECRUITING Phase PHASE3